Skip to content

The peritoneal microvascular endothelial glycocalyx in peritoneal dialysis patients

The peritoneal microvascular endothelial glycocalyx in peritoneal dialysis patients - Peritoneal endothelial glycocalyx in PD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34683
Enrollment
80
Registered
2010-06-21
Start date
2010-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritoneal dialysis peritoneal vascular abnormalities

Interventions

None listed

Sponsors

AMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients with end stage renal disease starting peritoneal dialysis (PD) (at the moment of catheter implantation) or undergoing preemptive kidney transplantation; 2. Stable prevalent PD patients, free of acute inflammatory conditions and malignancy, undergoing any procedure involving the opening of the peritoneal cavity (kidney transplantation, incidental abdominal condition, PD related problems excluding recent peritonitis (4weeks prior to the measurements), e.g. catheter replacement, catheter removal because of membrane failure); 3. A control group: kidney donors undergoing nephrectomy; 4. Age: 18-60 years

Exclusion criteria

Exclusion criteria: 1. unstable clinical condition 2. smoking 3. recent history of peritonitis (peritonitis less than 4weeks prior to the measurement) 4. use of antioxidants

Design outcomes

Primary

MeasureTime frame
1) The thickness of the peritoneal endothelial glycocalyx (as measured by Orthogonal Polarization Spectroscopy) 2) The thickness of the sublingual endothelial glycocalyx (as measured by Orthogonal Polarization Spectroscopy)

Secondary

MeasureTime frame
1) Parameters of peritoneal transport in PD patients 2) Morphological alterations of the peritoneal membrane 3) Glycocalyx constituents (hyaluronan, heparansulphate and syndecan-1) and their regulating enzymes (hyaluronidase and heparanase) in plasma and dialysate

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)